Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biolase Inc (BIOL)

Biolase Inc (BIOL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biolase Inc 27042 Towne Center Drive Suite 270 Lake Forest CA 92610 USA

www.biolase.com Employees: 157 P: 949-361-1200

Description:

Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.

Key Statistics

Overview:

Market Capitalization, $K 581
Enterprise Value, $K 10,261
Shares Outstanding, K 33,407
Annual Sales, $ 49,160 K
Annual Net Income, $ -20,630 K
Last Quarter Sales, $ 11,560 K
Last Quarter Net Income, $ -2,800 K
EBIT, $ -16,530 K
EBITDA, $ -13,310 K
60-Month Beta 0.67
% of Insider Shareholders 0.27%
% of Institutional Shareholders 8.79%
Float, K 33,317
% Float 99.73%
Short Volume Ratio 0.40

Growth:

1-Year Return -99.08%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth 6.50%
5-Year Earnings Growth 98.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 08/08/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -6.09
EPS Growth vs. Prev Qtr 77.78%
EPS Growth vs. Prev Year 99.10%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.010 on 06/24/05
Dividend Payable Date 07/12/05
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 07/28/23

BIOL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -55.31%
Profit Margin % -41.97%
Debt/Equity -6.31
Price/Sales 0.05
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.06
Interest Coverage -7.73

BIOL Dividends

Date Value
06/24/05 $0.0100
04/21/05 $0.0100
02/08/05 $0.0100
12/13/04 $0.0100
10/08/04 $0.0100
08/12/04 $0.0100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar